|
|
| You Just Secured $50 Million. Now On To The Hard Part: Clinical Trials | Guest Column | By Tom Wells, 4C Associates | 4C Associates' life sciences director Tom Wells explores common pitfalls of early-stage biotechs' transition into clinical trials and shows how early involvement of sourcing professionals can improve delivery, control spend, and help retain oversight. |
|
|
|
|
|
|
|
| Gain Instant Access To HEOR Education With On-Demand Programs | Product | ISPOR—The Professional Society for Health Economics and Outcomes Research | The ISPOR Education Center provides instant access to Health Economics and Outcomes Research education with on-demand programs delivered through a personalized and flexible learning platform. |
|
|
|
|
|
| Optimizing Oncology And Rare Disease Clinical Trials | Q&A | By Dave Selkirk, Ergomed Clinical Research | Dive into the history and accomplishments of Ergomed, a mid-sized, full-service contract research organization (CRO), with a specialized focus on oncology and rare disease clinical research. |
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
Connect With Clinical Leader: |
|
|
|